2022
DOI: 10.1016/j.bcp.2022.115165
|View full text |Cite
|
Sign up to set email alerts
|

Novel pharmacological inhibition of JMJD3 improves necrotizing enterocolitis by attenuating the inflammatory response and ameliorating intestinal injury

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 50 publications
0
5
0
Order By: Relevance
“…It has been reported that GSK‐J4 worked as a specific inhibitor of KDM6B in the treatment of inflammatory diseases 32,33 . In the current study, the repeat intrathecal (i.t.)…”
Section: Resultsmentioning
confidence: 78%
See 2 more Smart Citations
“…It has been reported that GSK‐J4 worked as a specific inhibitor of KDM6B in the treatment of inflammatory diseases 32,33 . In the current study, the repeat intrathecal (i.t.)…”
Section: Resultsmentioning
confidence: 78%
“…It has been reported that GSK‐J4 worked as a specific inhibitor of KDM6B in the treatment of inflammatory diseases. 32 , 33 In the current study, the repeat intrathecal (i.t.) injections of GSK‐J4 at doses of 5, 25, and 50 μg were performed to examine the role of KDM6B in the CFA‐induced inflammatory pain.…”
Section: Resultsmentioning
confidence: 96%
See 1 more Smart Citation
“…JMJD3 depletion negated downstream NF-κB proinflammatory signaling and subsequently reduced the LPS-stimulated upregulation of TNF-α, IL-1β, and IL-6 [ 44 ]. Furthermore, JMJD3 inhibition improved necrotizing enterocolitis (NEC) by attenuating the inflammatory response and ameliorating intestinal injury via the NF-κB and JAK2/STAT3 pathways in NEC mice [ 59 ]. Remarkably, targeting JMJD3 not only holds therapeutic potential for the treatment of inflammatory diseases but also represents a potential target for the treatment of IBD.…”
Section: Discussionmentioning
confidence: 99%
“…A large amount of evidence suggests that histone demethylation played an important role in intestinal inflammatory responses and the transformation to colorectal cancer (CRC) [ 184 ]. Ma et al [ 185 ] showed in necrotizing colitis mice that KDM6B was activated by STAT3 and participated in JAK2/STAT3 pathway to enhance the transcription of inflammatory genes. Besides, KDM6B might interact with NF-κB to activate the transcription of TNF-a/Il1b/Il6 and ultimately aggravated intestinal inflammatory damage.…”
Section: Kdms and Inflammatory Diseasesmentioning
confidence: 99%